October 29, 2019 Atomic Spectroscopy Clinical Research/Diagn.

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

Basel, 29 October 2019 Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc. Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) (“Spark”) today announced that Roche has extended the offering period of its previously announced tender offer to purchase all of the outstanding shares... Read more

October 21, 2019 Atomic Spectroscopy

Roche’s Tecentriq in combination with Avastin increased overall survival and progression-free survival in people with unresectable hepatocellular carcinoma

Basel, 21 October 2019 Roche’s Tecentriq in combination with Avastin increased overall survival and progression-free survival in people with unresectable hepatocellular carcinoma First Phase III cancer immunotherapy study to show an improvement in overall survival and progression-free survival for the treatment of the most common form of liver cancer Data will be submitted to health... Read more

October 10, 2019 Atomic Spectroscopy Microscopy Molecular Spectroscopy

Nobel Prize 2019 winner John B. Goodenough uses WITec Raman microscopes for Li-Ion Battery research

This year’s Nobel Prize in Chemistry was awarded to John B. Goodenough, M. Stanley Whittingham and Akira Yoshino “for the development of lithium-ion batteries.” https://www.nobelprize.org/prizes/chemistry/2019/summary/ Raman microscopy is a well-established and compelling technique for the characterization of electrochemical materials. John B. Goodenough’s research group at the University of Texas in Austin relies on a WITec... Read more

September 30, 2019 Atomic Spectroscopy Clinical Research/Diagn.

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

Basel, 30 September 2019 Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc. Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) (“Spark”) today announced that Roche has extended the offering period of its previously announced tender offer to purchase all of the outstanding shares... Read more

September 27, 2019 Atomic Spectroscopy Bio/Pharma/CRO PR/Corporate

Roche’s Tecentriq in combination with Avastin shows encouraging results in Phase Ib study of people with unresectable hepatocellular carcinoma

Basel, 27 September 2019 Roche’s Tecentriq in combination with Avastin shows encouraging results in Phase Ib study of people with unresectable hepatocellular carcinoma The study showed a confirmed objective response rate of 36% for people treated with the Tecentriq and Avastin combination in unresectable hepatocellular carcinoma who have not received prior systemic therapy The combination... Read more

September 4, 2019 Atomic Spectroscopy Lab Top-10 Product Launch

Bruker Announces New D8 DISCOVER PlusTM X-ray Diffraction (XRD) Solutions

D8 DISCOVER Plus TM with non-coplanar arm and MONTEL Plus TM optic CHIBA, Japan – September 4, 2019 – At the Japan Analytical Scientific Instruments Show (JASIS), Bruker today announced the release of new D8 DISCOVER PlusTM X-ray diffraction (XRD) solutions, featuring the new non-coplanar arm and the MONTEL PlusTM X-ray optics. The new non-coplanar arm allows the D8 DISCOVER Plus to perform in-plane diffraction... Read more

September 3, 2019 Atomic Spectroscopy Clinical Research/Diagn.

Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

Basel, 03 September 2019 Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc. Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) (“Spark”) today announced that Roche has extended the offering period of its previously announced tender offer to purchase all of the outstanding shares... Read more

August 27, 2019 Atomic Spectroscopy

Carrying out Research at Sea

The world’s first hybrid cruise ship has ZEISS microscopes on board Customer Story Launched in July 2019, MS Roald Amundsen cruise ship is the first of the two new hybrid-powered expedition ships in Hurtigruten’s fleet. Named after the Norwegian explorer who was first to cross Antarctica and reach the South Pole in 1911, the cruise... Read more